{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:55:46Z","timestamp":1780872946820,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Science and Technology Project of Changzhou","award":["CJ20243023"],"award-info":[{"award-number":["CJ20243023"]}]},{"name":"Changzhou Third People's Hospital","award":["Key Talents Project"],"award-info":[{"award-number":["Key Talents Project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06314-9","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T10:44:50Z","timestamp":1755168290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of fatty liver index and metabolic dysfunction-associated steatotic liver disease on the risk of benign prostatic hyperplasia in older male adults"],"prefix":"10.1186","volume":"25","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"1","key":"6314_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211(1):11\u20139.","journal-title":"J Urol"},{"issue":"11","key":"6314_CR2","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","volume":"3","author":"The global","year":"2022","unstructured":"The global. regional, and National burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet Healthy Longev. 2022;3(11):e754\u201376.","journal-title":"Lancet Healthy Longev"},{"key":"6314_CR3","first-page":"205","volume":"16","author":"G Xu","year":"2024","unstructured":"Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X. The etiology and pathogenesis of benign prostatic hyperplasia: the roles of sex hormones and anatomy. Res Rep Urol. 2024;16:205\u201314.","journal-title":"Res Rep Urol"},{"issue":"6","key":"6314_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"6314_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.15184","volume":"1538","author":"W Fan","year":"2024","unstructured":"Fan W, Bradford TM, T\u00f6r\u00f6k NJ. Metabolic dysfunction-associated liver disease and diabetes: matrix remodeling, fibrosis, and therapeutic implications. Ann N Y Acad Sci. 2024;1538(1):21\u201333.","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"6314_CR6","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.3346\/jkms.2020.35.e164","volume":"35","author":"GE Chung","year":"2020","unstructured":"Chung GE, Yim JY, Kim D, Kwak MS, Yang JI, Park B, et al. Nonalcoholic fatty liver disease is associated with benign prostate hyperplasia. J Korean Med Sci. 2020;35(22):e164.","journal-title":"J Korean Med Sci"},{"key":"6314_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"6314_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00345-014-1392-4","volume":"33","author":"GI Russo","year":"2015","unstructured":"Russo GI, Cimino S, Fragal\u00e0 E, Privitera S, La Vignera S, Condorelli R, et al. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia\/lower urinary tract symptoms: new insights from an Italian cross-sectional study. World J Urol. 2015;33(5):743\u201351.","journal-title":"World J Urol"},{"issue":"1","key":"6314_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","volume":"21","author":"J Park","year":"2022","unstructured":"Park J, Kim G, Kim BS, Han KD, Kwon SY, Park SH, et al. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2022;21(1):53.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"6314_CR10","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6314_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","volume":"161","author":"A Fuchs","year":"2021","unstructured":"Fuchs A, Samovski D, Smith GI, Cifarelli V, Farabi SS, Yoshino J, et al. Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. Gastroenterology. 2021;161(3):968\u2013e8112.","journal-title":"Gastroenterology"},{"issue":"1","key":"6314_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/pros.21041","volume":"70","author":"A Vikram","year":"2010","unstructured":"Vikram A, Jena GB, Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia. Prostate. 2010;70(1):79\u201389.","journal-title":"Prostate"},{"issue":"9","key":"6314_CR13","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/jcmm.13109","volume":"21","author":"FLL Sarmento-Cabral","year":"2017","unstructured":"Sarmento-Cabral FLL, Herrero-Aguayo A, Gahete V, Casta\u00f1o MD, Luque JP. Obesity and metabolic dysfunction severely influence prostate cell function: Role of insulin and IGF1. J Cell Mol Med. 2017;21(9):1893\u2013904.","journal-title":"J Cell Mol Med"},{"key":"6314_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.554078","volume":"12","author":"R Cannarella","year":"2021","unstructured":"Cannarella R, Condorelli RA, Barbagallo F, La Vignera S, Calogero AE. Endocrinology of the aging prostate: current concepts. Front Endocrinol (Lausanne). 2021;12: 554078.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6314_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175762","volume":"950","author":"NH El-Shafei","year":"2023","unstructured":"El-Shafei NH, Zaafan MA, Kandil EA, Sayed RH. Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1\/PI3K\/AKT\/FOXO signaling. Eur J Pharmacol. 2023;950: 175762.","journal-title":"Eur J Pharmacol"},{"key":"6314_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123192","volume":"358","author":"X Fu","year":"2024","unstructured":"Fu X, Wang Y, Lu Y, Liu J, Li H. Association between metabolic syndrome and benign prostatic hyperplasia: the underlying molecular connection. Life Sci. 2024;358: 123192.","journal-title":"Life Sci"},{"issue":"1","key":"6314_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrurol.2010.207","volume":"8","author":"CK Ho","year":"2011","unstructured":"Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8(1):29\u201341.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"6314_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 2016;19(1):7\u201313.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"6314_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/aje\/kwp406","volume":"171","author":"JM Schenk","year":"2010","unstructured":"Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, et al. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2010;171(5):571\u201382.","journal-title":"Am J Epidemiol"},{"issue":"16","key":"6314_CR20","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/pros.23237","volume":"76","author":"GI Russo","year":"2016","unstructured":"Russo GI, Cimino S, Castelli T, Favilla V, Gacci M, Carini M, et al. Benign prostatic hyperplasia, metabolic syndrome and non-alcoholic fatty liver disease: is metaflammation the link?? Prostate. 2016;76(16):1528\u201335.","journal-title":"Prostate"},{"issue":"3","key":"6314_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2605.2009.00972.x","volume":"33","author":"B Fibbi","year":"2010","unstructured":"Fibbi B, Penna G, Morelli A, Adorini L, Maggi M. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl. 2010;33(3):475\u201388.","journal-title":"Int J Androl"},{"issue":"3","key":"6314_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103511","volume":"23","author":"V Liedtke","year":"2024","unstructured":"Liedtke V, St\u00f6ckle M, Junker K, Roggenbuck D. Benign prostatic hyperplasia - a novel autoimmune disease with a potential therapy consequence? Autoimmun Rev. 2024;23(3): 103511.","journal-title":"Autoimmun Rev"},{"issue":"48","key":"6314_CR23","doi-asserted-by":"publisher","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","volume":"20","author":"S Stojsavljevi\u0107","year":"2014","unstructured":"Stojsavljevi\u0107 S, Gomer\u010di\u0107 Pal\u010di\u0107 M, Virovi\u0107 Juki\u0107 L, Smir\u010di\u0107 Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(48):18070\u201391.","journal-title":"World J Gastroenterol"},{"key":"6314_CR24","doi-asserted-by":"publisher","first-page":"43771","DOI":"10.1038\/srep43771","volume":"7","author":"S Fu","year":"2017","unstructured":"Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, et al. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771.","journal-title":"Sci Rep"},{"issue":"1","key":"6314_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111754","volume":"387","author":"B Zhang","year":"2020","unstructured":"Zhang B, Chen X, Xie C, Chen Z, Liu Y, Ru F, et al. Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI. Exp Cell Res. 2020;387(1): 111754.","journal-title":"Exp Cell Res"},{"key":"6314_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2021.10.007","volume":"163","author":"W Li","year":"2022","unstructured":"Li W, Liu J, Cai J, Zhang XJ, Zhang P, She ZG, et al. NAFLD as a continuous driver in the whole spectrum of vascular disease. J Mol Cell Cardiol. 2022;163:118\u201332.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"6314_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13643-022-01914-7","volume":"11","author":"L Lin","year":"2022","unstructured":"Lin L, Li P, Liu X, Xie X, Liu L, Singh AK, et al. Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia. Syst Rev. 2022;11(1):60.","journal-title":"Syst Rev"},{"key":"6314_CR28","doi-asserted-by":"crossref","unstructured":"Piras IS, DiStefano JK. Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression. Life Sci Alliance. 2024;7(6):e202302517.","DOI":"10.26508\/lsa.202302517"},{"key":"6314_CR29","unstructured":"Shankar E, Bhaskaran N, MacLennan GT, Liu G, Daneshgari F, Gupta S. Inflammatory signaling involved in High-Fat diet induced prostate diseases. J Urol Res. 2015;2(1):1018."},{"issue":"12","key":"6314_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00011-017-1088-5","volume":"66","author":"K Bandil","year":"2017","unstructured":"Bandil K, Singhal P, Dogra A, Rawal SK, Doval DC, Varshney AK, et al. Association of snps\/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population. Inflamm Res. 2017;66(12):1085\u201397.","journal-title":"Inflamm Res"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06314-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:26:18Z","timestamp":1757456778000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06314-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6314"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06314-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by the National Center for Health Statistics Ethics Review Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. As NHANES is a publicly accessible database, the Changzhou Third People\u2019s Hospital Ethics Committee granted approval to waive ethical review and approved the study protocol [02A-A2024018].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}